DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /PI3K/Akt/mTOR PathwayPI3K/Akt/mTOR Pathway
  5. /AktAkt
  6. /EngasertibEngasertib
Chemical structure of CAS 1313439-71-2

Engasertib

In Stock•Starting at $547 for 1 mg•Purity ≥ 99%
CAS No.1313439-71-2
MDL No.N/A
MFC25H25N3O3
MW415.50
InChI KeyBPHCAPAOSHZYJY-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg99%$547In Stock
5 mg99%$1192In Stock
10 mg99%$1923In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1313439-71-2
Product NameEngasertib

Associated Conditions

hereditary hemorrhagic telangiectasia
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Inhibition of AKT enhances chemotherapy efficacy and synergistically interacts with targeting of the Inhibitor of apoptosis proteins in oesophageal adenocarcinoma.

Scientific reports • Vol. 14, Issue 1 • 2024
PMID: 39739112PMC: PMC11686190DOI: 10.1038/s41598-024-83912-4

Identification and development of a subtype-selective allosteric AKT inhibitor suitable for clinical development.

Scientific reports • Vol. 12, Issue 1 • 2022
PMID: 36127435PMC: PMC9489722DOI: 10.1038/s41598-022-20208-5

Documentation

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact